Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

By Christy Santhosh and Kamal Choudhury (Reuters) -Drug distributor Cardinal Health said on Thursday it may need to increase prices of some of its products if the proposed tariffs on Mexico go into ...

In its motion to dismiss, J&J asserted that the plaintiff did “not allege a concrete harm or injury-in-fact” — a claim with ...

In our new study, people told us they’d been fined for leaving home to access drug treatment programs – and still couldn’t ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

With prescription drug costs soaring, Illinois lawmakers announced legislation this week reviving efforts to create a ...

SaveHealth explores the potential prescription cost savings that can be achieved by leveraging cash prices and discount cards ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

During the year ending last August, according to preliminary estimates from the Centers for Disease Control and Prevention ...

To save taxpayer money and rebuild the economy, Congress should repeal Biden's poorly named Inflation Reduction Act ...

The widespread acceptance of the so-called GLP-1 drugs, Zepbound by Eli Lilly and Wegovy by Novo Nordisk, for weight loss has created a game-changing dynamic for the overall health of the 72% of ...

The Trump administration’s Centers for Medicare and Medicaid Services (CMS) has signaled that it will be revamping the ...